Literature DB >> 20620415

Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome.

Kai Yao1, Hua Tu, Yong-Hong Li, Zi-Ke Qin, Zhuo-Wei Liu, Fang-Jian Zhou, Hui Han.   

Abstract

PURPOSE: Classic radical inguinal lymphadenectomy is associated with significant morbidity. Modified inguinal lymphadenectomy has been used to decrease the complication rate but it may compromise the oncological effect and depends on the use of intraoperative frozen sections, which may be inaccurate. We modified the technique of radical inguinal lymphadenectomy to decrease postoperative complications without compromising oncological effectiveness.
MATERIALS AND METHODS: We performed 150 modified radical inguinal dissections in 75 patients with penile carcinoma from February 1999 to September 2008. Patients underwent modified radical inguinal dissection characterized by an S-shaped incision, precisely separating layers using an anatomical landmark and preserving the fascia lata. The boundaries of dissection are the same as those of radical inguinal lymphadenectomy. Survival and morbidity data were retrospectively analyzed, and survival probabilities were calculated.
RESULTS: Followup ranged from 12 to 113 months. Overall 3-year survival was 92%, and for N0, N1, N2 and N3 disease it was 100%, 100%, 85% and 57.1%, respectively. A total of 37 complications occurred including wound infection (1.4%), skin necrosis (4.7%), lymphedema (13.9%), seroma (2.0%), lymphocele (2.0%) and deep venous thrombosis (0.7%).
CONCLUSIONS: Morbidity related to groin dissection in patients with penile carcinoma can be decreased and oncological effectiveness can be preserved using this modified inguinal dissection technique. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20620415     DOI: 10.1016/j.juro.2010.03.140

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort.

Authors:  X Melody Qu; D Robert Siemens; Alexander V Louie; Darwin Yip; Aamer Mahmud
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

2.  Robotic-assisted inguinal lymphadenectomy: a systematic review.

Authors:  Ioannis D Gkegkes; Evelyn Eleni Minis; Christos Iavazzo
Journal:  J Robot Surg       Date:  2018-05-05

Review 3.  Early experience of robotic-assisted inguinal lymphadenectomy: review of surgical outcomes relative to alternative approaches.

Authors:  Talar B Kharadjian; Surena F Matin; Curtis A Pettaway
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

4.  Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study.

Authors:  Zai-Shang Li; Chuang-Zhong Deng; Kai Yao; Yong Tang; Nan Liu; Peng Chen; Bin Wang; Xiang Li; Xiao-Feng Chen; Hong Liao; Qi-Wu Mi; Yong-Hong Lei; Qi Zhao; Pei-Zhen Zhao; Xue-Ying Li; Jie-Ping Chen; Qiang-Hua Zhou; Zi-Ke Qin; Zhuo-Wei Liu; Yong-Hong Li; Yun-Lin Ye; Hua Tu; Zi-Jun Zou; Xing Bi; Feng Yang; Ying-Ming Xiao; Jing Li; Xiang-Tian Lin; Wei-Cong Liang; Hui Han; Fang-Jian Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-22       Impact factor: 4.553

5.  Morbidity and risk factors for complications of inguinal lymph node dissection in penile cancer.

Authors:  Antoine Jeanne-Julien; Olivier Bouchot; Stéphane De Vergie; Julien Branchereau; Marie-Aimée Perrouin-Verbe; Jérôme Rigaud
Journal:  World J Urol       Date:  2022-10-08       Impact factor: 3.661

6.  The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection.

Authors:  Jian-Ye Liu; Yong-Hong Li; Zhi-Ling Zhang; Kai Yao; Yun-Lin Ye; Dan Xie; Hui Han; Zhou-Wei Liu; Zi-Ke Qin; Fang-Jian Zhou
Journal:  World J Urol       Date:  2013-02-28       Impact factor: 4.226

7.  Penile cancer: Perspective from a Canadian tertiary care centre.

Authors:  Benjamin Beech; Jonathan Izawa; Stephen Pautler; Joseph Chin; Nicholas Power
Journal:  Can Urol Assoc J       Date:  2015 Sep-Oct       Impact factor: 1.862

8.  [Lymph-node-positive penile cancer : Management and systemic therapy].

Authors:  A Aziz; S Milerski; K Kernig; C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 9.  Progress on Management of Penile Cancer in 2020.

Authors:  Mohamed E Ahmed; Mahmoud I Khalil; Mohamed H Kamel; R Jeffrey Karnes; Philippe E Spiess
Journal:  Curr Treat Options Oncol       Date:  2020-11-23

10.  Modification of N staging systems for penile cancer: a more precise prediction of prognosis.

Authors:  Z-S Li; K Yao; P Chen; B Wang; J-P Chen; Q-W Mi; Y-H Li; Z-W Liu; Z-K Qin; F-J Zhou; H Han
Journal:  Br J Cancer       Date:  2015-05-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.